- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-76-0000679

Raucmedi Pharmaceutical Private Limited
About Raucmedi Pharmaceutical Private Limited
Data last updated:
Raucmedi Pharmaceutical Private Limited is a private limited company based in Hapur, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2020PTC134796. Its GSTIN is 09AAKCR4492C1Z5 (Uttar Pradesh).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Vishal Kumar Chugh and Vikas Chugh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Na Railway Road Opposite Ganga Tawer Hapur Up – 245101, Uttar Pradesh, India – 245101.
As per the financials filed for FY 2024, the company reported a revenue of ₹1 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹2.5 Lakh (net margin -2.5%) and EBITDA of ₹16.42 Lakh (EBITDA margin 16.4%).
As per MCA filings, the company has open charges of ₹80 Lakh on record.
Raucmedi Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-76-0000679).
Company details
Recognitions & Rankings of Raucmedi Pharmaceutical
Contact details
Raucmedi Pharmaceutical Private Limited's registered office is in Hapur, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressNa Railway Road Opposite Ganga Tawer Hapur Up – 245101, Uttar Pradesh, India – 245101
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Raucmedi Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Raucmedi Pharmaceutical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Raucmedi Pharmaceutical Private Limited, buy the company report.
Financials of Raucmedi Pharmaceutical Private Limited
FY 2025 filings availableRaucmedi Pharmaceutical Private Limited reported revenue of ₹1 Cr (up 652% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 652% in the latest year. EBITDA rose 103% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹16.42 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹2.5 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 16.4% | |||
| Net Profit Margin | -2.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Raucmedi Pharmaceutical Private Limited, buy the company report.
Board of directors of Raucmedi Pharmaceutical Private Limited
Raucmedi Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishal Kumar Chugh | Director | 17 Sep 2020 | 6 Years 1 Months | Current |
| Vikas Chugh | Director | 17 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
Raucmedi Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sumaprigo Exports Private Limited | ₹1 Cr (FY 2024) | -26.0% | Chennai, Tamil Nadu, India | |||
| Paranoid Automation Systems Private Limited (OPC) | ₹1 Cr (FY 2025) | -37.0% | Pune, Maharashtra, India | |||
| Manjadi Foods Private Limited | ₹1 Cr (FY 2025) | 435.0% | Malappuram, Kerala, India | |||
| 7E Wellness India Private Limited | ₹1 Cr (FY 2025) | 82.0% | Indore, Madhya Pradesh, India | |||
| Brilliant Coatings Private Limited | ₹1 Cr (FY 2025) | -7.0% | Chennai, Tamil Nadu, India | |||
| Raucmedi Pharmaceutical Private Limitedthis company | ₹1 Cr (FY 2024) | -₹2.5 Lakh | -2.5% | 652.0% | Hapur, Uttar Pradesh, India | |
| Pruha Clothing Private Limited | ₹1 Cr (FY 2018) | 3135.0% | Bangalore, Karnataka, India | |||
| Shubhmangal Marketing Private Limited | ₹1 Cr (FY 2025) | -4.0% | Lucknow, Uttar Pradesh, India | |||
| Mats Avenue Floorings (OPC) Private Limited | ₹1 Cr (FY 2025) | -5.0% | Alappuzha, Kerala, India | |||
| Hak Cons Industries Private Limited | ₹1 Cr (FY 2025) | 424.0% | Barauni, Bihar, India | |||
| Legacy Dive Exim Private Limited | ₹1 Cr (FY 2025) | -40.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Raucmedi Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Aug 2021 | 100484396 | Others | ₹80 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Raucmedi Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Raucmedi Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Raucmedi Pharmaceutical Private Limited has 1 active EPFO establishment as of Apr 02, 2024.
GST
Raucmedi Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAKCR4492C1Z5 | Uttar Pradesh | Active | 13 May 2021 |
To see the full GST registrations and return filing status of Raucmedi Pharmaceutical Private Limited, buy the company report.
Recent activity
Raucmedi Pharmaceutical Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Vikas Chugh was appointed as Director on 17 Sep 2020.
Frequently asked questions
Raucmedi Pharmaceutical is an active private limited company based in Hapur, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 September 2020 (6+ years old) and is registered under CIN U51909UP2020PTC134796.
Raucmedi Pharmaceutical has 2 current directors:
- Vishal Kumar Chugh - Director
- Vikas Chugh - Director
The latest financial statements of Raucmedi Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Raucmedi Pharmaceutical is 09AAKCR4492C1Z5, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Raucmedi Pharmaceutical is U51909UP2020PTC134796. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raucmedi Pharmaceutical was incorporated on 17 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Raucmedi Pharmaceutical by revenue are Sumaprigo Exports Private Limited, Paranoid Automation Systems Private Limited (OPC), Manjadi Foods Private Limited, 7E Wellness India Private Limited, Brilliant Coatings Private Limited and 5 more, all in the same principal business activity (retail trading).
Vikas Chugh was appointed as Director on 17 Sep 2020. Vishal Kumar Chugh was appointed as Director on 17 Sep 2020.
Yes, Raucmedi Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-76-0000679).
The registered office of Raucmedi Pharmaceutical is at Na Railway Road Opposite Ganga Tawer Hapur Up – 245101, Uttar Pradesh, India – 245101.
Raucmedi Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

